2019 Abstracts

2019 Conference Abstracts

YearPaper ReferenceAbstract TitleAuthor
2019P001P001 -Challenges and successes of recruiting to a large cohort study - a research team's experience
Kelly White
2019P002P002 -Telephone Clinics As An Adjunct To Face-to-Face Consultations in Geographically Remote Regions of The West of Scotland.Oshorenua Aiyegbusi
2019P003P003 -Does presumed care mean missed care? Establishing a new clinic service for patients with PTDMAmy Riddell
2019P004P004 -Improving Patient Access to Diabetic Services on Unit Haemodialysis – A Pilot StudyAled Williams
2019P005P005 -Renal peer support: initial insights and findings from developing, delivering and evaluating a two year pilot serviceHope Clayton
2019P006Prevalence of physical and cognitive frailty in the low clearance populationAmbika Nedungadi
2019P007P007 -Variation in practice for administering iodinated contrast agents to CKD4-5 patients in the low clearance clinics in the UK: a benchmarking exercise.Michael Delaney
2019P008P008 -Superior performance status in haemodialysis inpatients does not always translate into a shorter length of stay.Sebastian Tullie
2019P009P009 -Adverse effects of oral glucocorticoid therapy in autoimmune disease – a quality improvement projectMaria Prasinou
2019P010P010 -Service development of kidney patient focussed counselling: 26 years of experience in a tertiary renal unitWigdan Hamza
2019P011 P011 -Exploring the experiences and concerns of staff and patients on an in-centre nocturnal haemodialysis programmeKatherine Hull
2019P012P012 -The London Membranous NetworkSanjana Gupta
2019P013P013 -Quality Improvement Project: Implementing New ‘ANCA sample’ pathwayYosra Dafalla
2019P014P014 -Outcomes of Multi-disciplinary Renal Emergency Simulations: Improved Participant Confidence in Communication and Team-workingDavid Rees
2019P015P015 -Dietitian supplementary prescribing – experience of prescribing phosphate binders and alfacalcidol for haemodialysis patientsElizabeth Rai
2019P016P016 -“Handing over the prescription pad.” - Dietetic supplementary prescribing results in timely prescriptions for CKD-MBD medications and aims to improve patient experience in a cohort of dialysis patients. Liz Brice
2019P017P017 -Embedding a culture of shared haemodialysis care to increase the prevalence of sharing HD care with patients.Jyoti Baharani
2019P018P018 -"Traffic Light" Water Jug Lids: A Hydration Quality Improvement Project in Older PatientsNeil Hoye
2019P019P019 -Share HD: the Birmingham experienceMiriam Berry
2019P020P020 -Are we doing enough? An audit exploring the management of adults with diabetes on a hospital-based haemodialysis unitAbigail Green
2019P021P021 -Lister Renal Department Review of Renal Intravenous Chemotherapy ServiceJocelyn Berdeprado
2019P022P022 -A retrospective review of the management of patients with a failing kidney transplant.Lubna Rashid
2019P023P023 -Delivering renal clinics differently: A cost and time efficient model for renal clinics with enhanced patient experience and peer support.Emma Montgomery
2019P024P024 -Native Renal Biopsy Complications within a Renal & Transplant UnitRichard Greenhow
2019P025P025 -Improving outcomes for haemodialysis new starters through implementation of an early review pathway – a trainee led quality improvement projectJaveria Peracha
2019P026P026 -A JOY IN WORK APPROACH TO SERVICE CHANGE AND STANDARDISATION Manasi Desai
2019P027P027 -Exploring Patient Safety Among Renal TraineesIan Logan
2019P028P028 -How to reach more patients with limited resources: a novel approach to delivering dietetic care to the low-clearance population. Sophi Buddo
2019P029P029 -Dialysis remote monitoring as an aid to telemedicine clinic: a single centre experienceSivakumar Sridharan
2019P030P030-Introduction of a lower cost branded calcineurin inhibitor for maintenance immunosuppression in kidney transplant recipients at a large UK transplant centreSaehara Khan
2019P031P031 -Impact of a multi-professional clinic designed to deliver personalised care to all patients who have recently started haemodialysis.Emma Montgomery
2019P033P033 -Association analysis of SNPs on Chromosome Y in renal disease in two cohorts.Kerry Anderson
2019P034P034 -Gene polymorphisms associated with microalbuminuria in 396,812 individuals from the UK Biobank cohortMarisa Canadas Garre
2019P035P035 -Analysis of risk variants through whole exome sequencing in steroid resistant nephrotic syndrome from a UK cohortCaroline Platt
2019P036P036 -Interpretation of rare heterozygous variants in recessive genes in a UK cohort of children with steroid resistant nephrotic syndrome Caroline Platt
2019P037P037 -Large scale whole-genome sequencing reveals the genetic architecture of primary membranoproliferative glomerulonephritis and C3 glomerulopathyDaniel Gale
2019P039P039 -Assessment of Microalbuminuria and its Clinical and Biochemical Correlates in Individuals with Sickle Cell Gene.Ayoola Odeyemi
2019P040P040 -Use of a gene panel for a diagnosis of cystic kidney disease and ciliopathy syndromes in an Omani populationJohn Sayer
2019P041P041 -Adult presentation of Gitelman syndrome – don’t ignore persistent hypokalemiaStephanie Urwin
2019P042P042 -Prescribing tolvaptan for autosomal dominant polycystic kidney disease within the general nephrology clinic settingMohammed Al-Talib
2019P043P043- Management of Gitelman syndrome in pregnancy: information resource for patientsRupa Kumar
2019P044P044 -X-linked Alport syndrome in the genomic medicine era - uncovering unusual clinical phenotypes of COL4A5 variantsAbhijit Dixit
2019P045P045 -Efficacy and side-effects of tolvaptan in autosomal dominant polycystic kidney disease (ADPKD) - a single centre experienceBryony Sedgwick
2019P046P046 -2 years' experience of a pharmacist lead tolvaptan clinic Claire Oates
2019P047P047 -Developing a multi-disciplinary regional Tuberous Sclerosis clinic: the Liverpool ExperienceAsheesh Sharma
2019P048P048 -A large family kindred with CFHR5 NephropathyPatrick Walsh
2019P049P049 -Clinical and genetic characteristics of autosomal dominant tubulointerstitial kidney disease – a case seriesAbhijit Dixit
2019P050P050 -The ADPKD Rare Diseases Group-2019 UpdateRichard Sandford
2019P051P051 -Arterial Stiffness is a Predictor for Acute Kidney Injury following Coronary Artery Bypass Graft SurgerySharlene Greenwood
2019P052P052 -Predicting risk of recurrent acute kidney injury: a systematic review Hilda Hounkpatin
2019P053P053 -Improving the recognition and management of Acute Kidney Injury in a large teaching hospital: A Unique Nurse Led Service. Rachel Fradley
2019P054P054 -COMPLIANCE OF ACUTE KIDNEY INJURY (AKI) BUNDLE IN PATIENTS ADMITTED WITH AKI STAGE 3Arun Varadaraju Gopu
2019P055P055 -Expanding and exploring AKI data submitted to the renal registry to gain better insight into patient cohorts of inpatients at an large acute hospital. Becky Bonfield
2019P056P056 -A qualitative study to explore nurses’ understanding of and attitudes to Acute Kidney Injury (AKI) and its managementChristina Armitage
2019P057P057 -An audit of the care provided to patients with Acute Kidney Injury (AKI) at a teaching hospital trust in the UKChristina Armitage
2019P058P058 -Admission diagnosis as predictor of severity and one-year mortality in patients with acute kidney injury – a clinical audit.Susil Pallikadavath
2019P059P059 -IMPACT OF BODY MASS INDEX ON RENAL AND MORTALITY OUTCOMES AFTER ACUTE KIDNEY INJURY: A SYSTEMATIC LITERATURE REVIEW Rochelle Blacklock
2019P060P060-Impact of acute kidney injury electronic alerts and use of ‘sick day rules’ on patient outcomes: an observational cohort study.David Baird
2019P061P061 -Causes and co-morbidities for e-alerts for acute kidney injury in pregnancyRouvick Gama
2019P062P062 -Recognition of pregnancy-related acute kidney injury with electronic alertsRouvick Gama
2019P063P063 -Weight-based Assessment of Fluid Overload in Patients with Acute Kidney InjuryBing Lun Chow
2019P064P064 -Can small rises in serum creatinine in hospitalised patients predict outcomes? Bnar Talabani
2019P065P065 -Impact on urine output monitoring of its removal as a trigger from a track and trigger systemEsteban Prieto
2019P066P066 -Chronic kidney disease in patients who have received renal support on ICUNaomi Edney
2019P067P067 -Acute Kidney Injury in Primary Care- 12 month observational studySteve Dickinson
2019P068P068 -The longer-term prognosis in Acute Kidney Injury (AKI) and the role of neoplasia. Mark Thomas
2019P069P069 -Prescribing pattern on the use of Statins following Acute Kidney Injury (AKI) Aleli Akani
2019P070P070 -Exploring the Feasibility of Urinary Biomarker Measurement (Nephrocheck®) to Stratify AKI Stage 1 in Medical Assessment UnitsMemoona Jawed
2019P071P071 -Dialysis dependent Acute Kidney Injury (DD-AKI) – developing a Regional collaborative study Javeria Peracha
2019P072P072 -Does baseline kidney function have an impact on outcomes of patients requiring renal replacement therapy on ITU?Benjamin Perren
2019P073P073 -Intervention at multiple stages in patient pathways lead to significant improvement in clinical outcomes in Acute Kidney Injury (AKI)Shalabh Srivastava
2019P074P074 -The Effect of Different definition of CKD progression on epidemiology of post AKI patients in a Large Prospective Parallel case control study of AKIIsma Kazmi
2019P075P075 -Five years on: The impact of introduction of electronic acute kidney injury alert (e-alert) and management pathway on patient care Adil Hazara
2019P076What do junior doctors know about Acute Kidney Injury? An educational audit and validation of an educational assessment tool.Matthew Morgan
2019P077P077 -ASSESSING SYMPTOM ASSESSMENT AND MANAGEMENT PROCESSES FOLLOWING THE ADMINISTRATION OF A PATIENT-REPORTED OUTCOME MEASURE TO HEMODIALYSIS PATIENTS IN ONTARIORebecca Lum
2019P078P078 -IMPLEMENTING A PATIENT-REPORTED OUTCOME MEASURE FOR HEMODIALYSIS PATIENTS IN ROUTINE CLINICAL CARE: PERSPECTIVES OF PATIENTS AND CLINICIANSRebecca Lum
2019P079P079 -Changes at the UK Renal Registry: new annual report, new data access application process and new research ready datasetKatharine Evans
2019P080P080 -The impact of prevalent stroke at critical junctures in the pathway of care for patients with kidney diseaseJames Tollitt
2019P081P081 -Comprehensive CKD Detection and coordination with Primary Care leads to reduction in late presentation for dialysis.Johann Nicholas
2019P082P082 -A detailed characterisation of cognitive impairment in patients with non-dialysis CKDJames Tollitt
2019P083P083 -Elucidating the relationship between renal inflammation and metabolism in chronic kidney disease in the mouse through integrative computational modelingAzadeh Harzandi
2019P084P084 -Distribution and impact of urological malignancies on renal progression and mortality in advanced chronic kidney diseaseRajkumar Chinnadurai
2019P085P085 -Cancer history is associated with mortality but not with renal progression in Non-Dialysis Chronic Kidney Disease Rajkumar Chinnadurai
2019P086P086 -Changing protein permeability with nephron loss; evidence for a human remnant nephron effect.Jamie Willows
2019P087P087 -The Prepare for Kidney Care Randomised Controlled Trial: Background, Intervention, Outcome Measures and ProgressFergus Caskey
2019P088P088- Development & Validation of a Multi-state Clinical Prediction Model in Chronic Kidney Disease and Renal Replacement TherapyMichael Barrowman
2019P089P089 -Development of a self-management behaviour scale for people on haemodialysis (HD)Helen Munro Wild
2019P090P090 -Improving the prescribing of statins in people with chronic kidney disease.Sue Shaw
2019P091P091 -Renal clinic – who is discharged and what are the outcomesRhodri Pyart
2019P092P092 -Sustaining Quality Improvement – what does the ASSIST-CKD project tell us?Nicola Thomas
2019P093P093 -Evaluation of a Community Kidney Service education programmeNicola Thomas
2019P094P094 -Development of an electronic patient-reported outcome measurement system for routine symptom monitoring and management in patients with advanced chronic kidney disease: The RePROM Study.Derek, K Kyte
2019P095P095 -Urinary alpha 1 acid glycoprotein and progression to end stage renal disease in chronic kidney disease: a prospective observational cohort study.Paul Cockwell
2019P096P096 -Opportunities to improve care through optimising use of ACEi and ARB in high risk chronic kidney diseaseAthif Hussain
2019P097P097 -Audit of statin use in a chronic kidney disease populationTariq Aljemmali
2019P098P098 -Making the impossible possible: overcoming challenges to delivering a randomised controlled trial comparing ‘Preparation for Renal Dialysis’ with ‘Preparation for Responsive Management’ in older, co-morbid patientsLeila Rooshenas
2019P100P100 -Most frequently reported barriers and benefits to exercise in peritoneal dialysis patientsCourtney Lightfoot
2019P101P101 -Using initiatives to facilitate recruitment to exercise studies for patients with chronic kidney diseaseJennifer Barsana
2019P102P102 -Cultural influences on physical activity and exercise beliefs in patients with Chronic Kidney Disease.Juliet Mayes
2019P103P103 -The impact of weekly group activities on an acute renal in-patient ward: Ending Pyjama ParalysisChris Gillespie
2019P104P104 -What can help people with chronic kidney disease (CKD) be more active?Heather Mackinnon
2019P105P105 -The effects of high intensity interval training on cardiovascular structure and function in renal transplant patients. The C-PACE-KD study Matthew Graham-Brown
2019P106P106 -THE RELATIVE IMPORTANCE OF PHYSICAL FRAILTY AND CARDIOVASCULAR FUNCTION AS MODIFIABLE PREDICTORS OF FALLS IN HAEMODIALYSIS PATIENTS: A PROSPECTIVE COHORT STUDYTobia Zanotto
2019P107P107 -Frailty, physical function, static balance and falls in CKD-5 patients on Heamodialysis Pelagia Koufaki
2019P108P108 -The acute physiological response to constant load exercise in end stage renal diseaseScott McGuire
2019P109P109 -Lighting a SPArK: Feasibility testing of a theory-driven intervention to increase physical activity (PA) in non-dialysis chronic kidney disease.Heather Mackinnon
2019P110P110 -The sedentary practices of renal patients – an observational study of behaviour on an acute renal ward. Susie McManus
2019P111P111 -Identification of symptom clusters using the Kidney Symptom Questionnaire in patients with CKD stages 3b-5 not on dialysisThomas Wilkinson
2019P112Symptom-burden and health-related quality of life in patients living with frailty and chronic kidney diseaseAndrew Nixon
2019P113P113 -The impact of acceptance of illness on quality of life outcomes for haemodialysis patients. Carol Stalker
2019P114P441 -The use of Patient-Reported Outcomes in patients with End Stage Renal Disease requiring treatment with Haemodialysis: a narrative review.Nicola Anderson
2019P115P115 -Designing a Wellbeing Month for Renal PatientsMargaret Eyre
2019P116P116 -Developing a patient survey to evaluate patient reported experience and facilitate service improvement in aHUS.Joanne Stout
2019P117P117 -The experience of Chronic Kidney Disease patients: The results of the 2017 and 2018 Renal Association / Kidney Care UK Patient Reported Experience Measure Catherine Stannard
2019P118P118 -Impact of extended haemodialysis using the Theranova dialyser on patient reported outcome measures (PROMs).Stephanie Bolton
2019P119P119 -Empowering and Supporting Self ManagementRachel Gair
2019P120“What else can you tell us about your experience of kidney care?” A qualitative analysis of patient comments from a free text box trialled in the 2018 Kidney PREM.Janine Hawkins
2019P121P121- IMPACT OF THE IMPLEMENTATION OF AN ASSISTED PERITONEAL DIALYSIS SERVICE ON PERITONEAL DIALYSIS INITIATIONAnnabel Boyer
2019P122Care experience with the 2% Chlorhexidine-infection at the exit site of the peritoneal dialysis patientsWanshan Chiang
2019P123P123 -Increasing The Prevalent Peritoneal Dialysis Patient Population Can Be Challenging.Hari Dukka
2019P124P124 -Case Report of the use of IP Daptomycin to treat VRE PD Peritonitis in a patient on APDBairavi Indrakumar
2019P125P125 -The effect of glucose absorption on changes in body composition in peritoneal dialysis patientsSteven Law
2019P126P126 -Travel and Peritoneal Dialysis: a safe combination Derick Manthiri
2019P127P127 -Measuring postural blood pressure to reduce the risk of falls in patients receiving peritoneal dialysisJennifer Allen
2019P128P128-Buried peritoneal dialysis catheters: A single centre experienceJennifer Allen
2019P129P129 -A risk score tool to improve recognition and management of peritoneal dialysis patients at risk of peritonitisJennifer Allen
2019P130P130 -Single centre outcome of PD related peritonitis in the UKJyoti Baharani
2019P131P131 - Assessment of compliance with PD planning at a tertiary referral renal unitOlatokunbo Abiodun
2019P132P132 -Continuous improvement is better than delayed perfection -Exploring time on therapy: taking quality improvement in PD a step furtherJyoti Baharani
2019P133P133 -Impact of remote patient management and monitoring system to support patients on automated peritoneal dialysis: One year on from implementation Asra Karim
2019P134P134 -Does peritoneal dialysis vintage affect relative leucocyte telomere length; a novel biomarker of ageing and mortality? Vasantha Muthuppalaniappan
2019P135P135 -Outcome measures for technique failure reported in peritoneal dialysis: a methodological systematic reviewEmma Elphick
2019P136P136 -Lupus Nephritis presenting as Tuberculosis Infection: a Case ReportMUHAMMAD TASSADUQ KHAN
2019P137P137 -Organisation of a Mock OSCE in a renal dialysis unit to give final year students experience of examining patients with signs in a structured environment.Pratik Solanki
2019P138P138 -Management of Severe Hyperkalaemia in adults.Nang Thin Zar Aye
2019P139P139 -The four horsemen of the health care IT apocalypse? A heckle from the audience.Eric Will
2019P139P139 -‘Doing what comes easily’ in Clinical Science?Eric Will
2019P139P139 -Clinical Registries – a meme?Eric Will
2019P140P140 -Making an old emergency new again - Simulation in response to the national hyperkalaemia patient safety alert.Rosa Montero
2019P141P141 -Diagnostic Pathway in Patients Presenting with Acute Kidney Injury Secondary to de novo Multiple Myeloma: A Two Centre ExperienceRitika Rana
2019P142P142 -Continuing To Take Time to Remember; Learning from an annual memorial service for renal patients, 2010-2018 and beyondEleanor King
2019P143P143 -Ethnic minority disparities in progression and mortality of pre-dialysis chronic kidney disease: a scoping reviewHilda Hounkpatin
2019P146P146 -Multi-morbidity patterns in patients with non-dialysis chronic kidney disease across England: a multi-centre cluster analysisThomas Wilkinson
2019P147P147 -Use of a comprehensive electronic health record database to identify and describe clinical associations with hyperkalaemia, the treatments instituted and associated clinical outcomesToby Humphrey
2019P148P148 -Insulin Use For The Treatment Of Acute HyperkalaemiaToby Humphrey
2019P149P149 -Acute Treatment of Hyperkalaemia with Intravenous Insulin – Comparative Evaluation of Patient CharacteristicsToby Humphrey
2019P150P150 -Feasibility of evaluation of the natural history of kidney disease using primary care electronic healthcare recordsFaye Cleary
2019P151P151 -Association of cancer history with mortality in end-stage renal disease patients on dialysisRajkumar Chinnadurai
2019P152P152 -DIFFERENCES IN SYMPTOM BURDEN AND THE IMPACT ON PHYSICAL FUNCTION ACROSS PRIMARY AND SECONDARY CARE CKD POPULATIONSAbina Dharmaratnam
2019P153P153 -Home Haemodialysis (HHD) with low dialysate volume (LDV) – The Green benefit Sunita Nair
2019P154P154 -The incidence of neurocognitive disorders in the BETSI-COG-CKD study; initial findings from this longitudinal investigation. Peter Hobson
2019P155P155 -An association of body mass index and kidney function among 13-year-old Malaysian adolescentsFathhullah Azmie Nawawi
2019P156P156 -Is there an association between heat exposure and decreased kidney function? A systematic reviewIda Karlsson
2019P157P157 -Hepatitis B vaccination as a cause of misdiagnosis of hepatitis B infection in haemodialysis patients: recommendations for avoiding diagnostic confusion.April Wilson
2019P158P158 -Population prevalence of impaired renal function in Uganda, Malawi and South Africa: baseline results of the ARK studyLaurie Tomlinson
2019P159P159-How to estimate Glomerular Filtration Rate in sub-Saharan Africa: design and methods of the African Research on Kidney Diseases (ARK) studyJosie Prynn
2019P160P160 -Protective effect of 1,25-dihydroxyvitamin D3 against contrast-induced nephropathy in diabetic rats through modulation of inflammatory responses, oxidative stress.Li Xiangling
2019P161P161 -RAPID APPEARANCE OF MEMBRANE-FREE, INTRACYTOPLASMIC INCLUSIONS IN THE RENAL PROXIMAL TUBULE EPITHELIAL CELL AFTER ISCHEMIA-REPERFUSION: A PATHOLOGICAL INVESTIGATION IN A PORCINE MODELDavid Gardner
2019P162P162 -ABT-263 administration depletes radiation induced senescent cells and reduces renal fibrosis after subsequent injuryKatie Mylonas
2019P163P163 -The role of SIRT5 in acute kidney injuryTimo Haschler
2019P164P164 -Murine models of renal ischaemia reperfusion injury: An opportunity for refinement using non-invasive monitoring methodsBettina Wilm
2019P165P165 -Ankyrin Repeat and Single KH domain 1 (ANKHD1) is a novel driver of polycystic kidney disease in vivo.Maria Fragiadaki
2019P166P166 -Growth hormone inhibition in Autosomal Dominant Polycystic Kidney DiseaseFiona Macleod
2019P167P167 -JAK2 inhibition halts the growth of polycystic kidney disease-derived epithelial cysts in vitro.Maria Fragiadaki
2019P168P168 -Vascular endothelial growth factor-C (VEGF-C) reduces cystogenesis in a human cellular model of polycystic kidney disease generated by CRISPR technologyNuria Perretta Tejedor
2019P169P169 -Vascular access in a district general hospital kidney unit: An 18 year experienceEmma Vaux
2019P170P170-Vascular Access for Haemodialysis in Pregnancy – clinical practice and outcomesHannah Blakey
2019P171P171 -A Systematic Review of Randomised Control Trials Comparing Cannulation Techniques for Arteriovenous Access for HaemodialysisCatherine Fielding
2019P172P172 -Haemodialysis Access Referral Form: A Systematic Approach in Referring Patients with Access ProblemHeidi Jimenez
2019P173P173 -Thrombolytic use in tunnelled haemodialysis catheters post implementation of Citra-Lock™ S catheter locking solution.Lisa Snelling
2019P174P174 -Arteriovenous fistulas aneurysms in a UK dialysis populationMelanie Field
2019P175P175-Patency of tunnelled central venous catheters for haemodialysis access: a systematic reviewHannah Blakey
2019P176P176 -“I’ve been diagnosed since 1970 and nobody has ever given me advice on diet or lifestyle”: A research priority setting workshop with CKD patients treated in primary careThomas Wilkinson
2019P177P177 -Greater knowledge of the health benefits of exercise is associated with higher physical activity levels in haemodialysis and peritoneal dialysis patients Jared Palmer
2019P178P178 -A Review of Anxiety and Depression amongst Haemodialysis Patients in the Western TrustAndrew Walker
2019P179P179 -Measuring shared decision making in routine clinical practice: Pilot of SDM-Q-9/-Doc and CollaboRATE scales within a low-clearance renal clinic.George Russam
2019P180P180 -Involvement of young people in a qualitative study that seeks to explore experiences of renal replacement therapy choice selection Sarah Ofori-Ansah
2019P181P181 -Identifying information needs of patients with IgA nephropathy: an innovative social media approachCristina Vasilica
2019P182P182-What sources of information do patients report being most important in decision making? Results from a multicentre questionnaire-based studyPippa Bailey
2019P183P183 -ShareHD: Integrating co-production into standard unit practiceSamantha Jennings
2019P184P184 -Patient focus group in addressing Immunosuppression related medication errors in a renal transplant centrePratik Solanki
2019P185P185 -Cultural acceptance of Type 2 Diabetes and Hypertension within Black, Asian and Minority Ethnic groups may hinder the awareness of chronic kidney disease in some UK communities – an opportunity to increase engagement. Gang Xu
2019P186P186 -Analysis of missed outpatient clinic appointments at a District General Hospital based Renal ServiceJo Taylor
2019P187P187 -‘Smarts’ a Virtual kidney assistant: Delivering high quality sustainable healthcare by empowering patients and healthcare teams. Co-produced with patients and healthcare professionalsArvind Nagra
2019P188P188 -‘PEEER’project- building Patient Empowerment, self Esteem, Employability and Resilience. A cost effective project: Arvind Nagra
2019P189P189 -Preemptive Therapy versus Universal Prophylaxis with Valganciclovir in minimizing the Risk of Cytomegalovirus Disease in Kidney Transplant RecipientsMUHAMMAD TASSADUQ KHAN
2019P190P190 -Frequency of Urinary Tract Infection by Multidrug Resistance Organisms and its Effect on Graft Function in Renal Transplant RecipientsMUHAMMAD TASSADUQ KHAN
2019P191P191 -Wound complications in early post-transplant period are associated with higher body mass index and poorer transplant outcomeIain Moore
2019P192P192 -RELATIONSHIP BETWEEN AORTIC DISTENSIBILITY, CORONARY ARTERY CALCIFICATION AND LEFT VENTRICULAR MASS IN RENAL TRANSPLANT RECIPIENTS: ASSESSMENTS FROM A CLINICAL TRIALJennifer S Lees
2019P193P193 -Cardiovascular disease and malignancy are the pre-eminent factors in transplant recipient mortality over a 5-year periodIain Moore
2019P194P194 -Endothelial Dysfunction and Blood Biomarkers in Kidney Transplant PatientsJoey Junarta
2019P195P195 -The Exercise in Renal Transplant Online weight management (ExeRTiOn) studyEllen Castle
2019P196P196 -Differences exist in kidney graft survival among female recipients stratified by donor sex and recipient age: a population cohort analysis from the United KingdomGeorgia Morgan
2019P197P197 -Sex-dependent clinical outcomes after kidney transplantation: a retrospective single-centre analysisGeorgia Morgan
2019P198P198 -Pre-transplant risk stratification for development of New Onset Diabetes After Transplantation (NODAT) in renal transplant recipientsHolly Mabillard
2019P199P199 - Pre-operative factors predicting early admission to the intensive care unit (ICU) after kidney transplantation.Nitin Abrol
2019P200P200 -PRE-OPERATIVE LEFT VENTRICULAR DYSFUNCTION AND POST KIDNEY TRANSPLANT COMPLICATIONS: A SINGLE-CENTRE ANALYSISZahrah Goolam-Mahomed
2019P201P201 -PRE-OPERATIVE MYOCARDIAL PERFUSION SCANS AND POST KIDNEY TRANSPLANT COMPLICATIONS: A SINGLE-CENTRE ANALYSISZahrah Goolam-Mahomed
2019P202P202 -VALVULAR LESIONS FROM ROUTINE PRE-OPERATIVE ECHOCARDIOGRAMS AND POST KIDNEY TRANSPLANT COMPLICATIONS: A SINGLE-CENTRE ANALYSISZahrah Goolam-Mahomed
2019P203P203 -Participant experiences and satisfaction from the CAVIAR studyKulli Kuningas
2019P204P204 -Impact of Hypertension and White Coat Hypertension on Renal Function and Blood Pressure Post Kidney DonationAruni Ratnayake
2019P205P205-Imaging challenges in transplant renal artery stenosisDavid Baird
2019P206P206 -A comparison between MDRD eGFR, creatinine clearance and kidney volume in renal transplant patientsMustakim Khandaker
2019P207P207 -What happens to diabetes medications after kidney transplants?Rosa Montero
2019P208P208 -Are we better at treating new onset diabetes after transplantation than type 2 diabetes mellitus in kidney transplant patients? Rosa Montero
2019P209P209 -Is blood sugar control better in type 1 diabetes mellitus or type 2 diabetes mellitus post renal transplant?Rosa Montero
2019P210P210 -Donor characteristics limit opportunities for black patients to receive renal transplantationJessica Kearney
2019P211P211 -Sleep quality in renal transplant recipients: an analysis using the Pittsburgh Sleep Quality IndexRoseanne Billany
2019P212P212 -Optimising outcomes for older patients: are adult children an underutilised ally in transplantation?Conor Oliver
2019P213P213 -Post-transplant DEXA scan results in correlation to incidence of fractureOmar Ragy
2019P214P214 -Cutaneous Malignancies in Renal Transplant Recipients - an analysis of 296 patients in “Sunny Cornwall”Steve Dickinson
2019P215P215 -The role of HLA mismatch and HLA-Cw7 in the development and clearance of polyoma virus following kidney transplantationJaya Patel
2019P216P216 -A clinical, immunogenetic and immunophenotyping re-evaluation of the risk factors for and consequences of CMV disease following kidney transplantation, with a focus on cardiovascular sequelaeJaya Patel
2019P217P217 -The Use of Dual and Triple Immunosuppression Strategies For Kidney Transplant Recipients at a Single Centre.Uwadiegwu Okoroafor
2019P218P218 -Anaemia management in four renal transplant recipients secondary to Ribavirin therapyCatherine Byrne
2019P219P219 -Skin cancer awareness and compliance with photo protection in long-term kidney transplant patients: A single centre cohort analysisAntonia Cronin
2019P220P220 -Prevalence of cancer in long-term kidney transplant patients: A single centre retrospective analysisAntonia Cronin
2019P221P221 -Body weight based initial dosing of tacrolimus post renal transplant- Is this an ideal approach?Rajkumar Chinnadurai
2019P222P222 -IgM-dominant Glomerular Immune Complex Deposition in the Renal Allograft: a case seriesNeeru Agarwal
2019P223P223 -Does a review of non-attenders to transplant clinic followed by intervention, offer an opportunity to re-engage patients and identify factors that lead to non-attendance?Joana Teles
2019P224P224 -Understanding clinician attitudes towards the influence of pre-transplant non-adherence on patient eligibility for renal transplantation. Abigail Hucker
2019P225P225 -Obesity obsession! Are we missing out potential transplant candidates?Nageen Anwar
2019P226P226-When polycystic kidneys are problematic: what nephrologists need to know about nephrectomy outcomesAaron Lake
2019P227P227 -Renal Transplantation in the Over 70s – Outcomes at A Single Centre.Monica Bowa- Nkhoma
2019P228P228 -MIBI or not MIBI? That is the question – cardiac considerations for potential kidney transplant recipientsAditi Verma
2019P229P229 -Is pre-renal transplant frailty and/or telomere length associated with length of stay and hospital readmissions post transplantation? Vasantha Muthuppalaniappan
2019P230P230 -Role of cinacalcet in post-transplant hyperparathyroidismIsmaa Kiani
2019P231P231 -Does size matter? Single central study looking at split function of live donor kidneys and their disparity in size.Arvind Singh
2019P232P232 -The development of multi-parameter flow cytometry panels to identify immune cells in renal transplant recipients and healthy controls Ganisha Fatania
2019P233P233 -Cardiovascular events in early chronic kidney disease and their association with markers of mineral bone diseaseMaarten Taal
2019P234P234 -The association between serum sodium concentration and albuminuria: a retrospective cohort studyNicholas Cole
2019P235P235 -Is there a rationale for biomarker stratified clinical trial for primary prevention of heart failure in chronic kidney disease?Shanmugakumar Chinnappa
2019P236P236 -Contraception practice amongst women with hypertensionHannah Bradshaw
2019P237P237 -PROGRESSION OF MYOCARADIAL FIBROSIS IN CKDManvir Kaur Hayer
2019P238P238 -Interruption of antiplatelets / anticoagulants and the risk of major adverse cardiovascular events (MACE) among patients undergoing renal biopsyYosra Dafalla
2019P239P239 -Clinical, Angiogenic and Immune System Markers Predict Pre-Eclampsia in Women with CKD During PregnancyNadia Sarween
2019P240P240-Progression and determinants of atherosclerosis and other vascular markers in patients with chronic kidney disease compared to healthy volunteers Debasish Banerjee
2019P241P241 -Recruitment and retention of participants to a pilot cluster randomised trial of an arts-based intervention for patients with end-stage kidney disease whilst receiving haemodialysis.Claire Carswell
2019P242P242 -Illness Perceptions In Renal Disease correlate with Wellbeing MarkersZoe Pittman
2019P243P243 -Exploring beliefs About Treatment in Advanced CKD and Relationship with Wellbeing and Outcome Zoe Pittman
2019P244P244 -The role of illness perceptions in designing psychological interventions for haemodialysis (HD) patients from South Asian backgroundsShivani Sharma
2019P245P245 -Vascular calcification in advanced CKD and its relationship with bone microstructuresSyazrah Salam
2019P246P246 -Setting targets for the management of mineral bone disorders in haemodialysis –do they help us?Colin Jones
2019P247P247 -Analysis of kidney stone composition in a contemporary, large, region wide cohort from the North East of EnglandJohn Sayer
2019P248P248 -The SIMPLIFIED Registry Trial: Towards Delivery of Streamlined Dialysis Trials in the United Kingdom.Thomas Hiemstra
2019P249Cinacalcet Treatment for Secondary Hyperparathyroidism, Single Centre Experience.Chera Arunachalam
2019P250P250 -Design of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Examine the Efficacy and Safety of SNF472 for Treating Calcific Uremic Arteriolopathy (Calciphylaxis)Stephan Miller
2019P251P251 -Oral vs intravenous (IV) pulsed alfacalcidol for the treatment of secondary hyperparathyroidism (SHPT) in haemodialysis patients – an audit of efficacy and costQiaoling Zhou
2019P252P252 -REAL-WORLD EXPERIENCE OF THE SAFETY AND EFFECTIVENESS OF SUCROFERRIC OXYHYDROXIDE IN UK DIALYSIS PATIENTS: AN INTERIM SUBGROUP ANALYSIS OF THE VERIFIE STUDYKerry Gardiner
2019P253P253 -Challenges accessing rehabilitation leads to increased length of stay for haemodialysis patientsIain Moore
2019P254P254 -Simulation Training: an under-utilised method of education for renal nurses?Karen Jenkins
2019P255P255 -Anticoagulation on haemodialysis: Switching from Tinzaparin to Dalteparin Jennifer S Lees
2019P256P256 -Does an individualised Treatment Plan Aimed at Improving the Management of Cardiac Instability on Haemodialysis improve Health and wellbeing?Sharon Huggins
2019P257P257 -The use of a Trigger Tool to detect harm during Haemodialysis: A prospective data review.Jemima Self
2019P258P258 -DEVELOPMENT OF AN IN VITRO SIMULATION MODEL TO INVESTIGATE HEMODYNAMIC RESPONSES DURING HAEMODIALYSIS Venkata R Latha Gullapudi
2019P259P259 -MEASURING PRESSURE WAVES IN DIALYSIS LINES TO DERIVE CONTINUOUS ARTERIAL BLOOD PRESSURE: PILOT WORK IN AN IN VITRO AND IN SILICO MODEL.Venkata R Latha Gullapudi
2019P260P260 -FREQUENCY ANALYSIS REVEALS UNIQUE HAEMODYNAMIC RESPONSES TO HAEMODIALYSIS: BASELINE RESULTS FROM THE ITREND STUDYVenkata R Latha Gullapudi
2019P261P261 -Absolute transcapillary plasma refilling rate and its variability during haemodialysis Nicos Mitsides
2019P262P262 -Medicines Optimisation in maintenance haemodialysis patients – Survey of UK renal unitsAlison Westley
2019P263P263 -Factors affecting the changes in dry weight among Hemodialysis patient populationShoab Saadat
2019P264P264 -Does a specific dialysis protocol in acute stroke patients affect morbidity and mortality: A four-year retrospective analysis.Charles Hall
2019P265P265 -Comparing haemodialysis protocols in neuro-trauma and acute stroke across London’s renal centresCharles Hall
2019P266P266 -Auditing the inter-dialytic weight gain of haemodialysis patients over a three year period from 2016 to 2018.Yukie Omichi
2019P267P267 -Acute Effects of Haemodialysis on Skeletal Muscle Perfusion, Metabolism and Function: A Systematic ReviewShatha Al Mushayt
2019P268P268 -Maintenance haemodialysis patient knowledge and appetite for medicines education – single centre surveyAlison Westley
2019P269P269 -Intradialytic cycling: putting the brakes on the rising costs of hospital resourcesAdam Hurt
2019P270P270 -What are the determinants of a late dialysis modality decision or decision change? A retrospective analysisAlice Culliford
2019P271P271 -What happens to patients who have unplanned dialysis starts due to late decision making or late decision changes after six months?Alice Culliford
2019P272P272 -Reducing our carbon footprint and resource use: A single centre experience of changing our practice to be more environmentally sustainable. A quality improvement project (QIP).Hannah Jenkins
2019P273P273 -Predicting change in dry weight of a Hemodialysis patient over the coming month using Xgboost Machine Learning algorithmShoab Saadat
2019P274P274 -A novel personalised nurse-led pathway improves clinical outcomes and reduces costs for patients commencing haemodialysis: a single centre quality improvement pilotAsheesh Sharma
2019P275P275 -Acetate-free biofiltration: an underappreciated treatment option in managing haemodialysis patients.Bethan England
2019P276P276 -Patients’ attitude towards access for haemodialysis.Jonny Varma
2019P277P277 -Impact of patient educational level on the prevalence of complications amongst haemodialysis patients.Jonny Varma
2019P278Paclitaxel assisted balloon Angioplasty of Venous stenosis in haEmodialysis access (PAVE); Study Protocol for the double-blind, multi-centre, randomised controlled trial to evaluate the efficacy of additional paclitaxel-coated balloon fistuloplasty versus plain balloon fistuloplasty only to preserve the patency of arteriovenous fistulae used for haemodialysisMichael Robson
2019P279P279 -Using Data to Drive Quality Improvement: The Haemodialysis Patient Safety Index One Year OnCatherine Fielding
2019P280P280 - Pericardial effusions in patients with renal disease: a single centre experienceAmarpreet Thind
2019P281P281 -Allergic reactions during haemodialysis treatment secondary to dialysis cathetersKateryna Macconaill
2019P282P282 -Clinical review of cause of death in adults undergoing in-center chronic haemodialysis between 2016 and 2018Mwayiwathu Prince Mtekateka
2019P283P283 -Change in frequency of haemodialysis related cramps over the past decade :- is modern dialysis better tolerated?Lisa Tang
2019P284P284 -Impact of Short-Term Change from Haemodiafiltration to High-Flux Haemodialysis on Phosphate ControlAlice Culliford
2019P285P285 -Personalised dialysate flow reduces cost without reduction in dialysis qualityStephen John
2019P286P458 -Evaluating symptom prevalence and management for patients on haemodialysis.Patrick Mcaleavey
2019P287P287 -Impact of major vascular intervention for peripheral vascular disease among diabetic patients on Haemodialysis – A retrospective studySivaramakrishnan Ramanarayanan
2019P288P288 -Our experiences working with the implementation of new eligibility criteria for patient transport for renal patients. Practical reflections on what we have learnt and suggestions for colleagues.Eleanor King
2019P289P289 -The association between salt intake scored by Scored Salt Questionnaire and markers of fluid overload in haemodialysis patientsManasi Desai
2019P290P290 - HOSPITALISATION RATES WITHIN ONE YEAR OF COMMENCEMENT OF RENAL REPLACEMENT THERAPY- SINGLE CENTRE EXPERIENCEVenkata R Latha Gullapudi
2019P291P291 -Use of a Portable Dialysis Machine to facilitate treatment of dialysis-dependent patients on the Intensive Care Unit at University Hospital Southampton NHS TrustKirsty Armstrong
2019P292P292 -‘I just don’t want to rock the boat’: uncovering barriers and facilitators to recruitment in the H4RT trial with an integrated QuinteT Recruitment Intervention.Fergus Caskey
2019P293P293-usage of renin-angiotensin aldosterone system (RAAS) blockade to reduce the cardiovascular risks in patients on regular haemodialysis - review of a practice in a single center dialysis unit Jonathan Chevassut
2019P294P294 -Burden in patients and their informal caregivers living with haemodialysis in Saudi Arabia: A cross sectional study.Bushra Alshammari
2019P295P295 -Development of nocturnal guidelines for home haemodialysis by special interest group for home haemodialysis nurses (SIGNhd-UK)Laura Thompson
2019P296P296 -The association of Diastolic Blood Pressure control with clinical outcomes in incident haemodialysis patientsRyan Kelly
2019P297P297 -Single central experience of femoral Tesio Catheters for Long term Haemodialysis use.Arvind Singh
2019P298P298 -Characterisation of Haemodynamics in Haemodialysis Patients with Chronic Kidney Disease using the non-invasive Ultrasonic Cardiac Output Monitor (USCOM): a prospective serial measurement, observational studyDena Pitrola
2019P299P299 -The role of a young adult transition nurse in a renal serviceVictoria Carnall
2019P300P300 -Evidencing the impact of a young adult service: specialist support results in a sustained decrease in clinic non-attendance over 8 yearsTerri Ellwood
2019P301P301 -Kidney disease is the commonest cause of secondary hypertension in young adultsJames Savage
2019P302P302-The national residential project for young adults with CKD.Laura Baines
2019P303Meeting the needs of Young Adults with Inflammatory Kidney Diseases – A Service EvaluationMatthew Morgan
2019P304P304 -Relapse of ANCA-associated vasculitis with recurrence of pyoderma gangrenosum and de novo pulmonary haemorrhageMatthew Beresford
2019P305P305 -Variable response to induction therapy and significant burden of treatment adverse events over the first 12 months of remission induction treatment in ANCA Associated Vasculitis (AAV) Patients – a study of routine clinical practice Peter Rutherford
2019P306P306 -Uptake of the pneumococcal and influenza vaccine in patients with ANCA-associated vasculitisEllen Kay
2019P307P307 -Changes in Body Mass Index (BMI) in patients with ANCA Associated Vasculitis (AAV) following initiation of induction therapy: a single centre cohort studyNina Brown
2019P308P308 -Long term outcomes of patients with ANCA associated vasculitis presenting with severe renal dysfunctionAnisha Tanna
2019P309P309 -THE LONGITUDINAL COURSE OF FATIGUE IN ANCA ASSOCIATED VASCULITISDimitrious Chanouzas
2019P310P310-Utility of a one-stop joint ENT-Vasculitis clinic in the management of relapsing ANCA-associated vasculitisDimitrious Chanouzas
2019P311P311 -Risk stratification tools in ANCA-associated glomerulonephritisChristopher Saleh
2019P312P312 -Diffuse Alveolar Haemorrhage Secondary to Lung Biopsy Proven Anti-GBM Disease with Negative Circulating Anti-GBM Antibodies by Standard ELISA – Case Report –Yasser Al-Mula Abed
2019P313P313 -A quality improvement project on the management of serum phosphate levels in adult haemodialysis patients, focusing on patient education and intensive renal dietetic reviewJaimeet Jassal
2019P314P314 -Factors associated with change in skin autofluorescence in dialysis patients: a prospective study.Daniela Viramontes Horner
2019P315P315 -Exploring the relationship between habitual dietary zinc intake, appetite, and total energy consumed in CKDEleanor Gore
2019P316P316 -ASSOCIATION BETWEEN DIETARY COMPONENTS AND VASCULAR STIFFNESS: ASSESSMENTS FROM RENAL TRANSPLANT RECIPIENTS PARTICIPATING IN A CLINICAL TRIAL Jennifer S Lees
2019P317P317 -How handgrip strength changes over the course of a haemodialysis session.Nicola Fernandez
2019P318P318 -Investigating the fluid and salt knowledge of patients within an ethnically diverse haemodialysis populationKatie Durman
2019P319P319 -Dietary factors associated with obesity in acute kidney injury: a cross-sectional studyRochelle Blacklock
2019P320P320 -Auditing the use of water-soluble vitamin supplementation in haemodialysis patients against European Renal Best Practice and Renal Association guidelines.Leia Kenney
2019P321P321 -The efficacy of oral probiotic, prebiotic and synbiotic supplementation in modulating gut derived circulatory toxic particles associated with mortality in dialysis patients: a systematic review and meta-analysis of randomised controlled trialsDaniel March
2019P322P322 -Post-operative nutritional management of Simultaneous pancreas and kidney transplant patients- Current practices in UK and IrelandStella Kourtellidou
2019P323P323 -Assessing the effectiveness of a modified X-PERT programme on dietary patterns in patients with diabetes and end stage renal disease (ESRD)Sandra Tan
2019P324P324 -Impact of dietetic intervention on skin autofluorescence and nutritional status in dialysis patients: a proof of principle studyDaniela Viramontes Horner
2019P325P325 -An audit to compare the difference between actual nutritional intakes versus nutritional requirements of ward haemodialysis patients. Zoe Ramsey
2019P326P326 -An examination of the dietitian workload on the renal ward.Joanna Finney
2019P327P327 -An audit on nutritional screening practice in patients with Chronic kidney diseaseManasi Desai
2019P328P328 -Exploring parent and adult-child experiences of support and decision making with polycystic kidney disease: A joint interview case studyLucina Wilde
2019P329P329 -Experience of genomics through 100,000 Genomes Project for paediatric renal rare disease patients at a specialised hospital. Maria Kokocinska
2019P330P330 -Eculizumab Safety: 5-Year Experience From the Global aHUS RegistryRodney Gilbert
2019P331P331 -Syndromic C3 glomerulopathy reveals a shared genetic risk factor with age-related macular degenerationGemma Thompson
2019P332P332 -A Novel SGPL-1 gene mutation causing a congenital nephrotic syndrome with associated primary adrenal insufficiencyDean Wallace
2019P333P333 -Prevalence of co-morbidities and their impact on survival of conservatively managed patients with stage 5 chronic kidney disease Kirsty Ward
2019P334P334 -One size does not fit all - A regional networked approach to optimising care to frail and elderly renal patients in South London.Kate Shepherd
2019P335P335 -Single centre experience of Conservative Kidney Management (CKM) for End Stage Renal Disease (ESRD) in elderly patients.Rishana Shuaib
2019P336P336 -How Can Renal Specialist Nurses Recognise and Respond to Frailty in the Pre-Dialysis Clinic?Andrew Mooney
2019P337P337 -What is the Benefit of Having a Geriatrician in the Low Clearance Clinic?Andrew Mooney
2019P338P338 -THe East and NoRth LOndon DIabetes Cohort Study (HEROIC): Rationale, Study Design and Outline ProtocolBen Caplin
2019P339P339 -Diabetes in patients receiving renal replacement therapy – the challenges of using registry dataRhodri Pyart
2019P340P115- TRPC6 binding to and activation of calpain regulates podocyte motilityLouise Farmer
2019P341P341 -The role of the G-actin sequestering peptide Thymosin Beta-4 in renal podocyte functionWilliam Mason
2019P342P342 -Post-translational regulation of endothelial derived CCN proteins in response to uremic serum from haemodialysis patientsNihil Chitalia
2019P343P343 -Uraemic sera-induced in-vitro calcification of human aortic smooth muscle cells involves regulation of Klotho and RUNX2Ken Farrington
2019P345P345 -Know your PLCE: A Role for PLCε in Controlling the Podocyte’s Response to TGF-B1Carl May
2019P346P346 -A proteomic roadmap comparing mechanisms of action of antifibrotics in an in-vitro model of TGF-β1-induced fibrogenesis in renal fibroblastsQihe Xu
2019P347P347 -Proteomic landscape of an in-vitro model of TGF-β1-induced fibrogenesis in renal fibroblastsQihe Xu
2019P348P348 -The role of GATA3 in bone morphogenetic protein 7 (BMP7) dependent prevention and reversal of myofibroblast phenotypeIrina Grigorieva
2019P349P349 -Multiparametric Renal MRI to Assess Structure and Function in Chronic Kidney DiseaseRebecca Noble
2019P350P350 -DETERMINING OPTIMAL TECHNIQUE FOR TISSUE FIXATION FOR EX-VIVO MRI IMAGING OF PORCINE KIDNEYSIsma Kazmi
2019P351P351 -Extracellular electrical resistance is inversely associated with tissue ionic sodium status and serum osmolality – implications for bioimpedance-derived hydration status in chronic kidney diseaseNicos Mitsides
2019P352P352 -The utility of magnetic resonance native T1 mapping for renal tissue characterisation in patients with IgA NephropathyMatthew Graham-Brown
2019P353P353 -Remote urine dipstick analysis for faster treatment of urinary tract infections using smartphone technologyRachel Middleton
2019P354P354 -Enhanced education leads to enhanced careAnca Ichim
2019P355P355 -Improving Patient Pathways Using Information Technology – PRESCHOOL learning toolChristopher Swan
2019P356P356 -Overcoming Isolation in Home Haemodialysis Patients Christopher Swan
2019P357P357- Short frequent haemodialysis at home does not appear to be associated with accelerated loss of residual renal functionHannah Beckwith
2019P358P358 -The Effect of Dialysis Modality Choice on Cognitive Functions in Patients with End Stage Renal Failure : A Systematic Review and Meta-analysisHatem Ali
2019P359P359 -CAN CONTINUOUS QUALITY IMPROVEMENT TO MAINTAIN A PERITONEAL DIALYSIS PROGRAMMEJyoti Baharani
2019P360P360 -PATIENTS’ PERCEPTION OF AUTOMATED PERITONEAL DIALYSIS REMOTE MONITORINGJyoti Baharani
2019P361P361 -Sharing practices and standards to improve sustainability of home haemodialysis globally. SIGNhd Global.Laura Thompson
2019P362P362 -Home dialysis for profound deaf patient: a case studySarah Ofori-Ansah
2019P363P363-Improving access to home haemodialysis for patients and education for in-centre Haemodialysis staff using a dialysis roadshow approachJyoti Baharani
2019P364P364 -Assist-HHD Study: A feasibility study Into staff-assisted Home Hemodialysis (aHHD) as an alternative dialysis modalityKunaal Kharbanda
2019P365P365 -Virtual Home Haemodialysis Review Tool (VH2RT): A Framework For Managing a Large Home Haemodialysis ProgrammeKunaal Kharbanda
2019P366P366 -Tolvaptan, An innovative treatment or a disappointment for ADKPD patients? A single centre's experience.Declan Keenan
2019P367P367 -THE ACUTE USE OF VELTASSA (PATIROMER) IN A TERTIARY RENAL UNITAmin Oomatia
2019P368P368-Investigation of the receptor mediated drug-creatinine interaction using trimethoprim in advanced chronic kidney disease- A pilot studyRajkumar Chinnadurai
2019P369P369 -Impact of chronic kidney disease on the drugs eliminated predominantly through a non-renal route: A proof of concept study with citalopramRajkumar Chinnadurai
2019P370P370 -Is oral vitamin B12 and folate supplementation (Renavit®) adequate in patients on high-flux haemodialysis and haemodiafiltration ?Clare Morlidge
2019P371P371 -Does chronic kidney disease affect the non-renal elimination of calcineurin inhibitors? Rajkumar Chinnadurai
2019P372P372 -The effect of prophylactic Tinzaparin on anti-Xa levels in patients with Chronic Kidney Disease 3-5. Seema Jham
2019P373P373 -Prescribing Safety Indicators In Patients With Chronic Kidney Disease: A Systematic Review Fiona Smith
2019P374P374 -The effects of tolvaptan on liver and kidney function in patients with Autosomal Dominant Polycystic Kidney Disease Matt Hall
2019P375P375 -Cockroft-Gault vs CKD-EPI for estimating GFR when dosing aminoglycosidesJoanna Willis
2019P376P376 -Clinical evaluation of biosimilar anti-CD20 monoclonal antibody with Rituximab in the treatment of ANCA-Associated Vasculitis Anna Iacovou
2019P377P377 -Mycophenolate mofetil in Lupus Nephritis – effective and safe over at least 10 years, a single centre experience.Hannah Beckwith
2019P378P378 -Fibrillary glomerulonephritis: A case series (a single centre experience) Zay Htet
2019P379P379 -Infective complications following Rituximab treatment – A single centre experienceLaura Gillis
2019P380P380 -A case of post infectious glomerulonephrits secondary to streptcoccus parasanguinis endocarditisGemma Thompson
2019P381P381 -Randomised Controlled Trial Protocol: The Use of Rituximab In the treatment of Nephrotic Glomerulonephritis (TURING)Lisa Willcocks
2019P382P382-Long term renal outcomes in patients with IgA vasculitis: A single-centre retrospective cohort studyChee Kay Cheung
2019P383P383 -Treatment of idiopathic membranous nephropathy using mycophenolate mofetil: a case seriesHannah Ariff
2019P384P384 -Benefit or burden: a systematic review and meta-analysis of treatment outcomes of ANCA-associated vasculitis in patients over the age of 75 years Adam Morris
2019P385P385 -Using long term outcome data to redefine proteinuria and eGFR endpoints for lupus nephritis trials: proteinuria targets need not be so stringentHannah Wilson
2019P386P386 -Comparison of treatment in a large cohort of lupus nephritis: Excellent long-term outcome with no difference in response or flare between oral steroid and steroid-free regimensHannah Wilson
2019P387P387 -Single Centre Experience of Rituximab Use in Nephrotic SyndromeTharindra N Somasinghe
2019P388P388 -Belimumab treatment offers a new steroid avoiding opportunity for non renal lupus activity in patients with lupus nephritis.Sarah Gleeson
2019P389Ovarian protection in patients receiving cyclophosphamide for lupus nephritisSarah Gleeson
2019P390P390 -Self-limiting nephrotic syndrome, acute kidney injury, and red cell aplasia – a case report of parvovirus associated glomerulonephritisStephanie Urwin
2019P391P391 -Long term outcomes of rituximab treatment in membranous nephropathyLina Nikolopoulou
2019P392P392 -Outcomes of renal vasculitis over 20 years in a tertiary renal unit Helena Edwards
2019P393P393 -CARDIOVASCULAR DISEASE IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITISAllyson Egan
2019P394P394 -RENAL INVOLVEMENT IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITISAllyson Egan
2019P395P395 -Relapse rate in systemic lupus erythematosus with or without lupus nephritisDimitrious Chanouzas
2019P396P396 -A single centre retrospective review of acute kidney injury in neonates with congenital diaphragmatic herniaAoife Ryan
2019P397P397 -Clinical Practice Guideline: Monitoring children and young people with, and at risk of developing Autosomal Dominant Polycystic Kidney Disease (ADPKD)Matko Marlais
2019P398P398 - HNF1B mutations are associated with an evolving tubulopathy in childhoodShazia Adalat
2019P399P399 -Sarcoidosis-associated renal impairment – a single centre experienceTariq Aljemmali
2019P400P400 -CHARACTERISING FUMADERM-INDUCED FANCONI SYNDROME: A CASE SERIESElizabeth Wan
2019P401P133 -Retrospective review of acute interstitial nephritis: a 12-year single centre experienceMahzuz Karim
2019P402P402 -The role of the calprotectin/ RAGE/ TLR4 axis in ANCA-Associated vasculitisTheresa Page
2019P403P403 -Complement in membranous nephropathyLina Nikolopoulou
2019P404P404 -Acute kidney injury (AKI)Nick Selby
2019P405P405 -AnaemiaSunil Bhandari
2019P406P406 -Autosomal dominant polycystic kidney disease (ADPKD)Tess Harris
2019P407P407 -Cardio-renalPaddy Mark
2019P408P408 -Chronic kidney disease, progression and biomarkersMaarten Taal
2019P409P409 -Exercise and lifestyleSharlene Greenwood
2019P410P410 -Glomerulonephritis (GN), lupus nephritis and vasculitisLiz Lightstone
2019P411P411 -Haemodialysis and vascular accessSandip Mitra
2019P412P412 -Chronic kidney disease mineral and bone disorderIndranil Dasgupta
2019P413P413 -Paediatric nephrologySally Johnson
2019P414P414 -Peritoneal dialysisMark Lambie
2019P415P415 -TransplantationSian Griffin
2019P416P416 -UK Renal Imaging Network (UKRIN)Susan Francis
2019P417P417 -UK Renal Trials Network (UKRTN)Thomas Hiemstra
2019P418P418 -UK Renal Fibrosis Network (UKRFN)Claire Sharpe
2019P419P419 -UK Renal Regenerative Medicine Network (UKRRMN) Bettina Wilm
2019P420P420 -Changes in regulatory and Th2-like populations, but not “senescence” phenotype characterise lymphocytes in older adults with non-dialysis CKD. Nadezhda Wall
2019P421P421 -An unusual clinical presentation of Cryptococcal infection in a post renal transplant patientGayani Nadeesha Nishathi Wickrama Arachchi Appuhamilage
2019P422P422 -Non-infective malakoplakia developing in a renal transplant and associated with poor outcome Madelena Stauss
2019P423P423 -Primary Renal Lymphoma: An Unusual Cause of Bilateral NephromegalyKhai Ping Ng
2019P424P424 -Acquired C1-inhibitor deficiency presenting with nephrotic syndromeJamie Willows
2019P425P425-Ruptured renal artery aneurysm leading to the diagnosis of Behçet´s diseaseAstrid Baumann
2019P426P426 -Malakoplakia in a renal transplantAmrita Dhutia
2019P427P427 -Iliohypogastric Nerve Injury Following Percutaneous Native Renal BiopsyAnna Forbes
2019P428P428 -A hidden cause of pulmonary oedema revealed by diagnostic persistence and teamwork.Stephanie Urwin
2019P429P429 -Burkholderia pseudomalei (meliodosis): An unusual cause of acute glomerulonephritis.Andrew Fry
2019P430P430 -A rare renal complication of ceftazidime therapyAshley Ferro
2019P431P431 -Seronegativity in biopsy-proven lupus nephritis: 4 cases observed in white Caucasian menCatherine Roberts
2019P432P432 -Resistant hypertension secondary to bilateral renal artery stenosis: a case reportJames Bannister
2019P433P433 -Recurrent AKI with loin pain in a Caucasian competitive cyclist. Urate is part of the story.Ashley Victoria Simpson
2019P434P434 -Severe systemic toxicity following intra-sac methotrexate treatment of an ectopic caesarean scar pregnancySarah Gleeson
2019P435P435 -The nephrotoxic risks of online shoppingLynn Zheng
2019P436P436 -Rat bite fever: a case reportRebecca Haggie
2019P437P437 -Successful treatment of active lupus in a patient on haemodialysis using belimumabSarah Gleeson
2019P438P438 -A young female with classical kidney biopsy appearances of anti-glomerular basement membrane disease in addition to thrombotic microangiopathy: a case reportKashif Anwari
2019P439P439 -Lessons from hyponatraemia management in a paediatric transplant recipient with extra-pontine myelinolysis and neurological sequelae.Victoria Harkins
2019P440P440 -Treatment of Glycogen Storage Disease Type 1a by combined Liver and Kidney TransplantationMukesh Kumar
2019P441P441 -Darn if it's dry, darn if it's wet!Muhammad Amaran
2019P442P442 -The effect of dose, frequency and responsiveness on the dose conversion ratio for switching darbepoetin-alfa to PEG-epoetin beta: preserving haemoglobin control in non-haemodialysis patients with CKDOwain Brooks
2019P443P443 -The use of an adaptive student-centred approach to Renal Clinical skills teaching for medical students at a UK based district general hospital: a quality improvement projectPratik Solanki
2019P444P444 -Hospital specialty consultants working in primary care undertaking virtual reviews to improve identification and management of chronic kidney diseaseSeema Singh
2019P445P445 -Development of a nursing teaching program for general medical and surgical topics on a renal wardPratik Solanki
2019P446P446 -Renal intra-professional education: A novel approach to up-skilling our renal trainees Kathryn Watson
2019P447Awareness and Attitude to Point of Care Creatinine Testing in a Tertiary Renal UnitDanilo Nebres
2019P448P448 -Benefits to the Nephrology MDT of Writing Outpatient Letters Directly to PatientsIan Logan
2019P449P449 -Tailoring consent discussions to account for the leading reasons for non-participation promotes recruitment to the SIMPLIFIED trial.Norman Vincent Madeja
2019P450P450-Renal trainees’ views on preparedness for consultant level workClare Castledine
2019P451P451 - Clinical nurses’ understanding of the role of Clinical Research Nurse in the renal unitCarlito Adan
2019P452P452 -A pilot study to examine the perceived benefits of reflexology in patients undergoing hospital base haemodialysis - SOLITUDEMichael Matthews
2019P453P453 -Exploring the UK renal social worker roleMaaike Seekles
2019P454P454 -Kidney Awareness Study DaySue Roberts
2019P455P455 -Th17 Cells: A Source of a Pathogenic Circulating Factor?Carl May
2019P456P456 -Dapagliflozin may attenuate renal fibrosis by inhibition of novel Smad3 linker region phosphorylationXinlu Pan
2019P457P457 -Proximal tubule damage is sustained in acute to chronic renal injury transition and specific early therapeutic intervention can limit the subsequent chronic kidney disease. Ekramun Nabi
2019P458P458 -Increased TACE and NLRP3 gene expression in chronic kidney disease (CKD) patients.Sean Mc Callion
2019P459P459 -Aristolochic acid and cisplatin differentially regulate retinoic acid activities in collecting duct cells and in kidneys of RARE-Luciferase miceQihe Xu
2019P460P460 -Endogenous retinoic acid activity in collecting duct cells is a convergence point of regulation by AKI/CKD mediatorsQihe Xu
2019P461P461 -Characterisation of Basal Myogenic Gene and Protein Expression in Skeletal Muscle of Advanced Chronic Kidney Disease PatientsTom O'sullivan
2019P462P462 -Using ultrasound scanning to investigate and treat a mouse model of obstructive uropathyNatalie Milmoe
2019P463P463 -Exploratory proteomics of urinary vesicles in chronic kidney disease progressionElisabetta AM Verderio
2019P464P464 -Kidney Patient Involvement Network (KPIN)Paula Ormandy
2019O82Reducing inpatient admissions by ambulating care for patients with acute kidney injury (AKI)Nicholas Annear
2019O325Myeloperoxidase inhibition: potential therapeutic target for crescentic glomerulonephritis?Marilina Antonelou
2019O253What mediates socioeconomic inequity in access to living-donor kidney transplantation? Results from a multicentre case-control studyPippa Bailey
2019O308IV iron dosing and infection risk in the PIVOTAL trial: a pre-specified secondary analysisSunil Bhandari
2019O474Heart failure and AKI after hospital admission with AKI among patients taking ACE inhibitors and ARBsPatrick Bidulka
2019O367Proliferative glomerulonephritis with non-organised monoclonal immunoglobulin deposits (PGNMID): a single-centre retrospective studySarah Blakey
2019O454Partnership working to provide bespoke renal welfare and debt management serviceJack Bramhall
2019O541CYCLE-HD: Improving cardiovascular health in patients with end stage renal disease using a structured programme of exercise. A randomised controlled trial.James Burton
2019O215Histological findings in acute interstitial nephritis – a role for scoring non-fibrotic inflammation.Emma Cannon
2019O423RNA regulation in renal disease: mutations in the ribonucleoproteins dyskerin and NOP10 are associated with a novel nephrotic syndrome Jennie Chandler
2019O124Natural history, outcomes and mortality associations of calciphylaxis: Update from the UK calciphylaxis registryRajkumar Chinnadurai
2019O407Moving towards a risk based model for timing of pre-dialysis planning: our unit’s experiencePaul Cockwell
2019O486Wide variance in transport provision for patients receiving in centre or satellite haemodialysis treatment in the UK: results of a national surveyPaul Cockwell
2019O512Identification of high-risk patient clusters based on extracellular matrix turnoverPaul Cockwell
2019O517The impact of utilising the Kidney Failure Risk Equation for referral into secondary care for individuals with chronic kidney disease in the UK Paul Cockwell
2019O398Development and implementation of MOVE: making exercise part of routine care for dialysis patients Jennifer Cooney
2019O453The effect of centre practice in initiating haemodialysis by an incremental approach compared to standard practice and short term patient survivalAndrew Davenport
2019O241Adeno-Associated Virus Vector Gene Therapy Ameliorates Nephrosis in a Podocin-deficient Mouse Model of Nephrotic SyndromeWen Yi Ding
2019O236Self-monitoring of Urine Specific Gravity using Study Smartphone Applications Promotes Adherence to High Water therapy and facilitates remote data capture in the DRINK Randomised TrialRagada El-damanawi
2019O389Chorioretinal thickness tracks disease activity in clinical ANCA vasculitisTariq Farrah
2019O478Association between non-malignant monoclonal gammopathy and risk of adverse outcomes in chronic kidney diseaseAnthony Fenton
2019O525Correlation between kidney sizes and split renal function in prospective living kidney donorsAnthony Fenton
2019O316How common is contrast induced acute kidney injury (CI-AKI) in patients undergoing coronary angiography and percutaneous coronary intervention (PCI)?Amy Forrester
2019O442The Kidney Quality Improvement Partnership (KQuIP): Developing and embedding Quality Improvement capability within the kidney community – a local, regional, and national approachRachel Gair
2019O156A novel heparanase inhibitor protects glomerular endothelial glycocalyx during diabetes mellitus Monica Gamez
2019O368Prophylactic eculizumab treatment significantly improves renal allograft survival in patients with atypical haemolytic uremic syndrome compared with historic controlsEmily Glover
2019O117Innate immune response biomarkers in peritoneal dialysis effluent as reliable diagnostic indicators of peritonitis - evaluation of a rapid diagnostic test deviceCate Goodlad
2019O85The effect of initiation of renin-angiotensin system inhibitors on haemoglobinGeorge Greenhall
2019O545A study of Factors AssoCiated with Treatment Resistant HYpertension (FACT-RHY): a description of phenotypical, physiological and biochemical characteristics of patients with true treatment-resistant hypertension compared to treated patients with hypertension.Mohammed Hameed
2019O415The functional consequences of myocardial fibrosis in chronic kidney disease Manvir Kaur Hayer
2019O67Outcomes in the first 90 days after starting dialysis – transition of the UK Renal Registry to capture of all acute and chronic dialysis sessionsBarny Hole
2019O108Temporal trends in prevalence of chronic kidney disease in England: comparison of nationally representative cross-sectional surveys from 2003 to 2016Hilda Hounkpatin
2019O319Lessons learned from the development and evaluation of a virtual renal clinic.Sally Hull
2019O381Increasing the prevalence of shared haemodialysis care at Salford Royal Foundation Trust dialysis unitsEmma Jenner
2019O522HLA antibody and Tacrolimus variability in transplant recipients during transition from paediatrics to regional adult units.Shilpa Kaki
2019O113Acute Kidney Disease - a new definition, but is it useful in describing renal outcomes following AKI?Isma Kazmi
2019O134Long Term Effects of Acute Kidney Injury on Chronic Kidney Disease and Patient Outcomes: 3-year Results from a Large Prospective Parallel Group Cohort StudyIsma Kazmi
2019O370Do clinical staff activate patients? The relationship between Clinician Support for Patient Activation and the Patient Activation Measure in In-centre haemodialysis patients.Maria Keriakos
2019O167Comparing active lifestyle intervention using renal dietician-led behaviour change techniques versus standard of care after kidney transplantation (CAVIAR): a randomised controlled trial.Kulli Kuningas
2019O270A novel small molecule therapy rescues trafficking of misfolded podocin and corrects Nephrotic Syndrome caused by a common podocin mutationValeryia Kuzmuk
2019O528An Unusual Infiltrative Cause of Acute-on-Chronic Kidney InjuryHugh Leonard
2019O76Physical activity and exercise behaviours of peritoneal dialysis patients in England: results from a multi-centre observational trialCourtney Lightfoot
2019O445Using three-dimensional imaging to study how kidney lymphatic vessels developDavid Long
2019O494Standards for Transport Provision for Patients receiving in centre or satellite unit haemodialysis: Finding a Way TogetherFiona Loud
2019O50Barriers to kidney transplantation in children – ATTOMic prospective national studyStephen Marks
2019O229Analysis of intensified immunosuppression response in genetically-stratified steroid resistant nephrotic syndrome (SRNS) patients predicts outcomes and suggests distinct immune mechanismsAnna Mason
2019O242Signalling Response Under Par: A PAR-1 mediated signalling pathway in podocytes is a consistent feature of ‘circulating factor’ initiated nephrotic syndrome.Carl May
2019O495Fostamatinib treatment of a new model of MPO-ANCA vasculitis in WKY rats induced by administration of a sub-nephritogenic dose of nephrotoxic serum after immunisation with human myeloperoxidaseStephen Mcadoo
2019O497Long-term follow up of a steroid-minimising regimen for remission-induction in ANCA associated vasculitisStephen Mcadoo
2019O439A paediatric AKI service: Improving recognition and reducing incidenceGrace Mccall
2019O334MinTac: A prospective, multicentre, randomised controlled trial of tacrolimus vs prednisolone for adults with de novo minimal change disease.Nicholas Medjeral-Thomas
2019O87Inspiring a generation: A Renal Taster Weekend for prospective nephrologistsAnjali Menon
2019O388The Electronic Frailty Index (eFI) Indicates Mortality Risk in End Stage Kidney Disease (ESKD) Patients on DialysisAndrew Mooney
2019O158Donor gender and recipient outcomes after kidney transplantation: a population cohort analysis from the United KingdomGeorgia Morgan
2019O30Healthcare related activity following kidney transplantation.Eleanor Murray
2019O341Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis – A randomised controlled trial.Lina Nikolopoulou
2019O21Developing an in situ simulation programme on renal emergencies to facilitate improvement in multidisciplinary workingAilish Nimmo
2019O212Prognostic accuracy of frailty screening methods in advanced chronic kidney diseaseAndrew Nixon
2019O329Longitudinal effects of depression on cognitive function in haemodialysis patientsAghogho Odudu
2019O240Characterisation of senescent renal epithelial cells in experimental renal disease reveals transcriptional heterogeneity at a single cell levelEoin O'Sullivan
2019O94Diabetes during pregnancy and congenital genitourinary malformations: A systematic review and meta-analysisMounika Parimi
2019O267Feasibility of non-contrast cardiac MR stress T1-mapping to assess coronary artery disease in patients on haemodialysisFederica Poli
2019O446A novel P2X7 knockout rat is not protected from experimental glomerulonephritis or vasculitisMaria Prendecki
2019O449The effect of P2X7 antagonism on nephrotoxic nephritisMaria Prendecki
2019O286Renal Outcome in Patients with Newly Diagnosed Multiple Myeloma: Results from the UK NCRI Myeloma XI trial.Ritika Rana
2019O484A Study Of Maternal and Fetal Outcomes in a Cohort of Pregnant Women with Chronic Kidney Disease Nadia Sarween
2019O248A model of cardiovascular disease in people with reduced renal function using routine healthcare dataClaire Simons
2019O18Poor advance care planning in older patients with end-stage renal disease: a qualitative interview study of nephrologists.Andrew Smyth
2019O375CKD-PAQ: Developing a tool for physical activity estimation in chronic kidney diseaseSivakumar Sridharan
2019O79Focal segmental necrotising glomerulonephritis associated with selective IgA deficiency: two case reports Madelena Stauss
2019O378The Impact of Acute Kidney Injury Requiring Haemodialysis on Patient Survival: 10 years of Prospective Data - An Australian PerspectiveBenjamin Talbot
2019O520Introducing a tool to implement Transplant First: Identifying barriers to transplant listing, measuring for improvement, and lessons learned from a pilot centre.Kerry Tomlinson
2019O536Comparative effects of oral anti-diabetic agents after metformin monotherapy in UK primary care: a propensity-score matched cohort studyLaurie Tomlinson
2019O359Live glomerular imaging in experimental crescentic glomerulonephritis reveals sequential glomerular infiltration of monocyte subsets with distinct effector functionsTabitha Turner-Stokes
2019O518Acceptability of alternate day dialysis regimes to patients on in-centre maintenance dialysis: a multi-centre surveyEnric Vilar
2019O12Skin autofluorescence and malnutrition as predictors of mortality in dialysis patients.Daniela Viramontes Horner
2019O25Clinical and biochemical characteristics of hypokalaemic patients: predictors of a genetic diagnosis of Gitelman or Bartter syndromeElizabeth Wan
2019O3124-hour versus spot urinary sodium and potassium measurements in adult hypertensive patients: a cohort validation studyElizabeth Wan
2019O129Conception intentions and pregnancy experiences amongst women of childbearing age on dialysisPhilip Webster
2019O244A programme of supervised exercise and multidisciplinary education (PREHAB) prevents deterioration in physical function and nutritional status in persons approaching and commencing dialysis Fiona Willingham
2019O417What information do staff use to involve patients in decisions about conservative management? A critical review of leaflets used in UK renal services.Anna Winterbottom